Ardelyx reported $504.51M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Amgen USD 95.64B 3.14B Jun/2026
Ardelyx USD 504.51M 2.9M Mar/2026
aTyr Pharma USD 79.65M 435.68M Mar/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Curis USD 29.69M 9.72M Mar/2026
Sanofi EUR 128.02B 1.22B Mar/2026
TG Therapeutics USD 1.64B 110.79M Jun/2026
United Therapeutics USD 7.22B 505.9M Jun/2026